Modeling Bladder Cancer in the Laboratory: Insights from Patient-Derived Organoids

Researchers summarize the methodologies for generatingp patient-derived organoids from patients with bladder cancer and discuss the current advancements in drug sensitivity testing, immunotherapy, living biobanks, drug screening, and mechanistic studies, highlighting their role in advancing personalized medicine.